SEC Comment Letter 0000000000-24-012079 to Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Oct. 30, 2024 · CIK: 0001106838 · Accession: 0000000000-24-012079
AI Filing Summary & Sentiment
File numbers found in text: 333-282850
Letter
October 30, 2024 Pankaj Mohan Chief Executive Officer Sonnet BioTherapeutics Holdings, Inc. 100 Overlook Center, Suite 102 Princeton, New Jersey 08540 Re:Sonnet BioTherapeutics Holdings, Inc. Registration Statement on Form S-1 Filed October 28, 2024 File No. 333-282850 Dear Pankaj Mohan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Steven M. Skolnick, Esq.
Show Raw Text
October 30, 2024
Pankaj Mohan
Chief Executive Officer
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center, Suite 102
Princeton, New Jersey 08540
Re:Sonnet BioTherapeutics Holdings, Inc.
Registration Statement on Form S-1
Filed October 28, 2024
File No. 333-282850
Dear Pankaj Mohan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Steven M. Skolnick, Esq.